Staten Island, NY, United States of America

Chengguo Dong

This inventor holds 24 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in ROR-Gamma Inhibitors. Top assignees: Vitae Pharmaceuticals, Inc., Pliant Therapeutics, Inc.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chengguo Dong. Retrieved from https://idiyas.com/inventor/chengguo-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 10 (Patent Applications = 19)

Average Co-Inventor Count = 11.7

ph-index = 9

Forward Citations = 140(Granted Patents)

Company Filing History:

22 out of 85

Vitae Pharmaceuticals, Inc.

patents

2 out of 16

Pliant Therapeutics, Inc.

patents

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

ROR-Gamma

Inhibitors

Liver X Receptor

Modulators

Amino Acids

Dihydropyrrolopyridine

Thiazolopyrrolidine

Isoindoline

Piperazine

Compounds

Menin-MLL Interaction

Drug Discovery

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312359 - Inhibitors of the menin-MLL interaction (2025-05-27),

2. 11739085 - Inhibitors of the menin-MLL interaction (2023-08-29),

3. 11560376 - Amino acid compounds and methods of use (2023-01-24),

4. 11535614 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2022-12-27),

5. 11479557 - Inhibitors of the menin-MLL interaction (2022-10-25),

6. 11001583 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2021-05-11),

7. 10899758 - Inhibitors of the menin-MLL interaction (2021-01-26),

8. 10807980 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2020-10-20),

9. 10793564 - Amino acid compounds and methods of use (2020-10-06),

10. 10683302 - Inhibitors of the menin-MLL interaction (2020-06-16),

11. 10399976 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2019-09-03),

12. 10144715 - Piperazine derivatives as liver X receptor modulators (2018-12-04),

13. 10087184 - Dihydropyrrolopyridine inhibitors of RORγ (2018-10-02),

14. 10047085 - Dihydropyrrolopyridine inhibitors of ROR-gamma (2018-08-14),

15. 9868748 - Thiazolopyrrolidine inhibitors of ROR- γ (2018-01-16),

Title: Chengguo Dong: Pioneering Inventor from Staten Island

Introduction: Chengguo Dong is a renowned inventor based in Staten Island, NY, known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Chengguo Dong holds several patents related to novel drug delivery systems and innovative pharmaceutical formulations that have revolutionized the industry.

Career Highlights: With a distinguished career spanning over two decades, Chengguo Dong has worked with leading research institutions and pharmaceutical companies to develop cutting-edge solutions for complex medical challenges.

Collaborations: Throughout his career, Chengguo Dong has collaborated with top scientists, researchers, and medical professionals to bring his inventions from concept to reality, resulting in life-changing advancements in healthcare.

Conclusion: Chengguo Dong's relentless pursuit of innovation and his passion for improving global health outcomes have solidified his reputation as a trailblazing inventor in the field of biotechnology and pharmaceuticals.

Profile summary based on public USPTO records.